News

David Krag, MD, Earns NIH and ARRA Grant for Work on Reducing Complications for Breast Cancer Patients

World-renown cancer researcher and S.D. Ireland Professor of Surgical Oncology at the University of Vermont, David Krag, MD, has been selected to receive funding from the National Institutes of Health (NIH) and the American Reinvestment and Recovery Act of 2009 (ARRA) to continue his work to reduce complications for breast cancer patients.

Selected as one of only 47 research projects to be funded in Vermont, Dr. Krag’s research is focused on developing “radiotracer” technology to identify cancerous lymph nodes in breast cancer patients.  This pioneering approach allows physicians to identify and remove only those lymph nodes which contain cancerous cells and leave healthy tissue in place.  This technique has been shown to effectively reduce the occurrence of severe complications of traditional treatments such as lymphedema, chronic numbness and potentially serious infections, improving treatment for thousands of patients.

“Before the Recovery Act funds, support for this large, randomized surgical trial for breast cancer patients was about to end,” says Dr. Krag.  “Now this project is fully back on track, which is phenomenal for the thousands of women who participated in this trial as well as for all future breast cancer patients.”

For more information about the NIH and ARRA grant and Dr. Krag’s work, visit http://recovery.nih.gov/stories/krag.php.

Dr. Krag’s cutting edge research in the fight to successfully treat cancer is also supported by the S.D. Ireland Cancer Research Fund which is dedicated to providing on going funding for focused cancer research at the University of Vermont.  Dr. Krag has been the holder of the S.D. Ireland Professorship of Surgical Oncology at UVM since 1999.

«
»

This entry was posted on Thursday, January 28th, 2010 at 10:49 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply